Skip to main content

Tweets

What a conference! Thanks to all those who stopped by! #ACR25 https://t.co/UMAqnPdK4t
Dr. John Cush @RheumNow ( View Tweet )
5 months 1 week ago
Sleep Apnea in Psoriatic Arthritis – A Wake Up Call Fatigue is one of the most disabling symptoms in psoriatic arthritis (PsA), yet its causes are often underexplored. At #ACR25, Abstract #0549, a possible hidden contributor was studied: obstructive sleep apnea (OSA). In a https://t.co/E3cy1Uss73
Dr. John Cush @RheumNow ( View Tweet )
5 months 1 week ago
We often see patients with MTX lab abnormalities but How frequent is MTX toxicity? Retrospective study 2500pts Rochester Epidemiology Project cohort 60% w/ ever lab abnormalities, but 4% attributed to MTX 0.87/100 patient year Organ injury event 0.02/100 patient year = 5 in https://t.co/w8oYUjj5Yp
Aurelie Najm @AurelieRheumo ( View Tweet )
5 months 1 week ago
Lung Disease in ANCA-associated Vasculitis Dr. Mike Putman discusses abstract 0721, "Pulmonary Manifestations of Granulomatosis with Polyangiitis and Microscopic Polyangiitis", presented at #ACR25. https://t.co/A5uKT4jG1I https://t.co/7E4k7QdiNK
Dr. John Cush @RheumNow ( View Tweet )
5 months 1 week ago
ACR2025 Day 3 Recap https://t.co/ZQ1mZePZ1S

Dr. John Cush @RheumNow ( View Tweet )

5 months 1 week ago
Disease activity associated with symtomatic knee OA and increased with increased KL grades Abst#2625 #ACR25 @RheumNow https://t.co/uCrdnVXk0J
Bella Mehta @bella_mehta ( View Tweet )
5 months 1 week ago
A deep dive into Lupus 🔬 Abstract 2601: Single-cell insights in SLE & pre-clinical autoimmunity 🔹 Plasmablast expansion → high disease activity & SLE risk 🔹 Metabolic activity varies by cell type 🔹 Established disease: ↑ glycolysis & OxPHOS changes @RheumNow #ACR25

Akhil Sood MD, MS @AkhilSoodMD ( View Tweet )

5 months 1 week ago
Head to head study of Secukinumab vs Ustekinumab. In TNFi-experienced PsA patients, the AgAIN trial shows secukinumab performed better than ustekinumab in HAQ-DI response (57.1% vs 27.0%, p=0.002) and across all endpoints (joint counts, pain, and skin outcomes). Fewer https://t.co/CDCWkLF5TW
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
5 months 1 week ago
Abstract 2360: Single-center lupus pregnancy cohort found that: 🔹 Absence of DORIS remission associated w/ adverse pregnancy outcomes (Pre-term, Pre-eclampsia) 🔹 This is along with known risk factors: antihypertensive use, prior nephritis, active disease @RheumNow #ACR25 https://t.co/STg1NBeFPo
Akhil Sood MD, MS @AkhilSoodMD ( View Tweet )
5 months 1 week ago
CDAI appropriately guided therapy escalation in RA, but not for everyone. Treatment adjustments were less likely in pts with public or no insurance. Even data-driven care can fall short when access barriers persist. @RheumNow #ACR25 Abstract#2616

Jiha Lee @JihaRheum ( View Tweet )

5 months 1 week ago
Reaadmissions in sle pregnancies from 66k patients Insurance and economics seem to be very important in predictions using machine learning. Abst#2629 #ACR25 @RheumNow https://t.co/x2oo9TOxoh
Bella Mehta @bella_mehta ( View Tweet )
5 months 1 week ago
In healthy women, preeclampsia was more common with: - increased calprotectin - decreased anti-CCP (very low levels) during pregnancy & this has good predictive capacity for future preeclampsia. Rheum pathophys can give insights into adjacent pathology #ACR25 ABST2628 @RheumNow https://t.co/7d5YB6n6XJ
David Liew @drdavidliew ( View Tweet )
5 months 1 week ago
×